Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-25 @ 9:54 PM
NCT ID: NCT04373551
Description: Adverse events are harmful occurrences to study participants, either study-related or non-study related. Study participation reflected a unique opportunity to provide referrals for social services as we collected data on depressive symptoms and intimate partner violence. Any participant who endorsed significant symptoms on either of these measures (or a participant who spontaneously reported these problems) was provided with a referral for services from the partnering clinic.
Frequency Threshold: 0
Time Frame: 2 years, 3 months
Study: NCT04373551
Study Brief: WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Cultural Adaptation of a Client-Provider Communication Tool The goal of the intervention is to strengthen the PrEP care continuum by developing and testing a culturally adapted client-provider communication tool designed to improve PrEP awareness, screening, engagement, retention, adherence, and persistence among individuals at increased risk for HIV seroconversion. Specifically, the intervention aims to reduce racial and gender disparities in PrEP uptake and use. Each enrolled participant took part in a pilot study evaluating the client-provider communication tool adapted for PrEP uptake among Black or African American cis-gender women and their healthcare providers in a pre-post intervention design. Eligibility criteria was expanded to include women of any race/ethnicity. Participating healthcare providers discussed PrEP with participants using the communication tool. 0 None 0 67 0 67 View
Serious Events(If Any):
Other Events(If Any):